Pay in installments of $7.24 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 17 - Jul 22
For Your Every Summer RSVP, with Code: SUMMER15
Description
Tirzepatide PeterMD Semaglutide Reduces Alcohol and Smoking Cravings, Study Finds Karmactive Por qu funcionan Ozempic y otros medicamentos para bajar de peso? The New York Times GLP 1 Support Plans Shop optavia




Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.7 ★★★★★
Based on 1804 reviews
Sort
Product Reviews
★★★★★ 5
Helps with it itching
I use this product to treat dermatitis herpetiformis breakouts from Celiac . Excellent value and very effective at releiving the late night itch.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 4, 2026
★★★★★ 5
My favorite soap!
I love this soap! Smells great and leaves my skin feeling soft and clean!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 3, 2026
★★★★★ 4
Works for acne
I bought this for my daughter. She loves it. However it doesn't last long
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 27, 2025
★★★★★ 5
Excelent
Excelent
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 26, 2026
★★★★★ 3
Good product
Nice soap but doesnt last long
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 7, 2026
recommand products
What to Expect First Day of GLP-1: Complete Guide
23.75
Healthy Weight Loss Medication Program
27.40
In a major new JAMA Oncology study, researchers examined health records from 86,632 adults with obesity, comparing those who used GLP-1 receptor agonists (like semaglutide or tirzepatide) to matched non-users. The findings
25.26
The Critical Role of Exercise in the GLP-1 Era: JAMA-published perspective by authors Dr. Steven Heymsfield of Pennington Biomedical and Drs. Daniel Lieberman and Daniel Aslan of Harvard University https://t.co/giPEq7gMF4 #Solutions #CellsToSociety #
26.03
Study comparing Mounjaro and Ozempic published in JAMA Internal Medicine
27.99




